We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+3.58%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$69.4B
AUM Growth
+$3.54B
Cap. Flow
+$1.44B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.44%
Holding
3,843
New
225
Increased
1,690
Reduced
1,576
Closed
217

Sector Composition

Rank Sector Weight
1 Technology 10.52%
2 Financials 9.29%
3 Healthcare 8.12%
4 Industrials 6.67%
5 Consumer Discretionary 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPN
3351
DELISTED
Superior Energy Services, Inc.
SPN
$119K ﹤0.01%
9,136
-8,475
-48% -$249K
DLR icon
3352
CALL
Digital Realty Trust
DLR
$71.7B
$118K ﹤0.01%
25,600
-600
-2% -$71.5K
MGF
3353
Aberdeen Government Markets Income Fund
MGF
$92.2M
$118K ﹤0.01%
+25,727
New +$116K
CVM icon
3354
CEL-SCI Corp
CVM
$30.1M
$117K ﹤0.01%
466
-1,426
-75% -$258K
RMTI icon
3355
Rockwell Medical
RMTI
$28.2M
$117K ﹤0.01%
352
-10
-3% -$5.08K
GRF
3356
Eagle Capital Growth Fund
GRF
$41.5M
$116K ﹤0.01%
14,589
+2,571
+21% +$19.7K
DISH
3357
CALL
DELISTED
DISH Network Corp.
DISH
$116K ﹤0.01%
+35,300
New +$1.25M
MU icon
3358
CALL
Micron Technology
MU
$991B
$115K ﹤0.01%
28,000
-400
-1% -$15.2K
TBBK icon
3359
The Bancorp
TBBK
$2.84B
$115K ﹤0.01%
12,941
-266
-2% -$2.45K
QEP
3360
DELISTED
QEP RESOURCES, INC.
QEP
$114K ﹤0.01%
15,723
-1,236
-7% -$9.01K
MNK
3361
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$112K ﹤0.01%
12,192
+1,321
+12% +$19.1K
AZUL
3362
CALL
DELISTED
Azul
AZUL
$109K ﹤0.01%
+23,200
New +$673K
NIO icon
3363
NIO
NIO
$11.9B
$109K ﹤0.01%
42,556
-4,865
-10% -$19.5K
XBI icon
3364
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$109K ﹤0.01%
42,700
+1,200
+3% +$102K
EEA
3365
European Equity Fund
EEA
$76.6M
$108K ﹤0.01%
+12,263
New +$107K
NCV
3366
Virtus Convertible & Income Fund
NCV
$390M
$108K ﹤0.01%
4,797
-892
-16% -$20.7K
UNP icon
3367
CALL
Union Pacific
UNP
$174B
$108K ﹤0.01%
59,000
-37,600
-39% -$6.44M
BEST
3368
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
$107K ﹤0.01%
971
SILV
3369
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
$107K ﹤0.01%
27,193
+4,519
+20% +$15.6K
RWGE
3370
DELISTED
Regalwood Global Energy Ltd. Class A Ordinary Shares
RWGE
$107K ﹤0.01%
10,500
UGP icon
3371
Ultrapar
UGP
$6.54B
$105K ﹤0.01%
+20,069
New +$109K
ALDX icon
3372
Aldeyra Therapeutics
ALDX
$93.5M
$103K ﹤0.01%
+17,100
New +$129K
BBD icon
3373
Banco Bradesco
BBD
$36.7B
$103K ﹤0.01%
+14,017
New +$95.8K
IYR icon
3374
CALL
iShares US Real Estate ETF
IYR
$4.57B
$103K ﹤0.01%
11,800
EPM icon
3375
Evolution Petroleum
EPM
$131M
$101K ﹤0.01%
14,144
+2,500
+21% +$16.9K

Similar funds

Raymond James & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Raymond James & Associates held 3,843 positions worth $69.4B, up 5.4% from $65.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Raymond James & Associates's Q2 2019 filing shows 225 new, 1,690 increased, 1,576 reduced and 217 closed positions. Its largest new stake was Dow Inc: 851,378 shares worth $42M. The largest sale was AbbVie, an estimated $134M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2019 buy was Dow Inc: 851,378 shares worth $42M.
  • Raymond James & Associates added most to Medtronic in Q2 2019, an estimated $157M increase.
  • Raymond James & Associates's biggest Q2 2019 reduction was AbbVie, cutting an estimated $134M.
  • Raymond James & Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $5.43M.
  • Raymond James & Associates's ten largest holdings make up 21% of its $69.4B portfolio in Q2 2019.
  • Raymond James & Associates opened 225 new positions and closed 217 in Q2 2019.
  • Raymond James & Associates's portfolio value rose 5.4% quarter-over-quarter to $69.4B.

Based on Raymond James & Associates's 13F filing for Q2 2019, filed 6 Aug 2019.